CClinicalTrials.gg
CompletedNCT03602313Updated Jul 26, 2018

Biomechanical Gait Analysis in Patients Post-Stroke

An interventional study of Body Weight Support Gait Training and Traditional Gait Training in CVA (Cerebrovascular Accident) and Stroke, sponsored by Florida Gulf Coast University. Completed. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-07-26.

Sponsored by Florida Gulf Coast University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 6 years 4 months after the study started (first participant enrolled Dec 2011, registered May 2018).
Phase
Not applicable
Study type
Interventional
Enrollment
48
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Randomized trial of patients with cerebrovascular accident (CVA) receiving traditional and body weight supported (BWS) gait training. Participants are enrolled and randomized upon entry into acute care and gait is evaluated within 48 hours of discharge from the rehabilitation hospital. Gait analysis is used to determine which of the two groups achieved gait parameters most similar to the normal gait of an age-matched population.

Read the detailed description

Potential participants are identified upon admission to acute care post cerebrovascular accident (CVA) and screened for inclusion. Informed consent is obtained from the patient and/or designee. Demographic information is obtained from the medical record, the patient and/or designee by the clinical coordinator. The participant is randomized into traditional gait training group or body weight support (BWS) group. The participant receives the required amount of physical therapy as directed by clinicians at the acute care facility and accrediting agencies.

The traditional gait training group will receive gait training as presently performed without additional modalities. The BWS group will received BWS gait training in lieu of traditional gait training. Participants will be treated in in-patient rehabilitation for a duration as determined by the clinical team; thus, the overall duration of care may be variable between participants. Time spent in gait training activities for both groups will be tracked by both service unit and by time (minutes).

Within 48 hours of discharge from the acute care facility, the participant will be transported to a separate site for kinematic gait analysis using a marker based motion capture system.

The procedure for gait analysis is as follows:

  1. Investigators will place reflective markers on the following areas using non-latex adhesive tape: top of the shoulders, bony part of the pelvis on the front and back, hips, front of the thighs, outside of the knees, front of the shins, outside of the ankles, first and fifth toes, and back of each heel.
  2. The participant will walk across the room in the gait analysis lab no more than 20 times at his/her choice of pace while the camera system records gait parameters and kinematics. He/she will be allowed to rest as needed during the data collection.
  3. The reflective markers and adhesive tape will be removed and the participant thanked for his/her participation.
02

Conditions studied

  • CVA (Cerebrovascular Accident)
  • Stroke

Browse trials for

Keywords

  • Body Weight Support
03

In context

Stroke

7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.

This study's enrollment of 48 is close to the median of 50 across 5,369 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

Florida Gulf Coast University is the lead sponsor of 16 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Current in-patient in acute care for Cerebrovascular accident (CVA),
  • Unilateral CVA affecting at least the lower limb, and
  • Medically stable as determined by the rehabilitation physician.

Exclusion criteria

Exclusion Criteria:

  • Previous (more than 1) CVA with residual lower limb deficit, and
  • Any lower extremity pathology on the affected side other than the effects of the CVA.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
48 participants (actual)

Study arms

  • Active comparator
    Traditional Gait Training

    The Traditional Gait Training group will receive gait training as presently performed without additional modalities.

    Other: Traditional Gait Training

  • Experimental
    Body Weight Support Training

    The Body Weight Support group will received body weight support gait training in lieu of traditional gait training.

    Device: Body Weight Support Gait Training

Interventions

  • DeviceBody Weight Support Gait Training

    Also known as: BSWTT, LiteGait

  • OtherTraditional Gait Training

    Also known as: Overground

06

What researchers measure

Primary outcomes

  1. Gait Speed

    Velocity of center of mass of the participant.

    Time frame: Collected in one 1-hour session after the patient has completed acute rehabilitation, approximately 21 days.

  2. Step Length

    Difference in position between the feet at heel strike, in the direction of forward motion.

    Time frame: Collected in one 1-hour session after the patient has completed acute rehabilitation, approximately 21 days.

  3. Step Width

    Difference in position between the feet at heel strike, in the direction normal to the direction of forward motion.

    Time frame: Collected in one 1-hour session after the patient has completed acute rehabilitation, approximately 21 days.

  4. Step Asymmetry

    The ratio of the difference of left and right step length over the stride length.

    Time frame: Collected in one 1-hour session after the patient has completed acute rehabilitation, approximately 21 days.

Secondary outcomes

  1. Gait Units

    Measure of the quantity of therapy received during the duration of care.

    Time frame: Measured at discharge, approximately 21 days

  2. Functional Independence Measure (FIM)

    A 17 items survey of patient independence in 2 domains, motor and cognition. It is used as a basic indicator of patient disability.

    Time frame: Admission of the FIM is completed within 72 hours of the start of a rehabilitation, and within 75 hours of discharge, approximately 21 days

  3. Length of Stay

    Total duration of care at the acute rehabilitation facility.

    Time frame: Approximately 21 days. Determined by the study clinicians based on severity of disability and rate of progress.

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 26, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03602313
Lead sponsor
Florida Gulf Coast University
Responsible party
Sponsor
First posted
Jul 26, 2018
Start date
Dec 6, 2011
Primary completion
Sep 17, 2015
Completion
Sep 17, 2015
Last update
Jul 26, 2018

Study contacts

Derek J Lura, PhD
principal investigator · Florida Gulf Coast University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion